Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
16 results
  • Internet searches for opioids predict future emergency department heroin admissions. [Journal Article]
    Drug Alcohol Depend. 2018 Sep 01; 190:166-169.Young SD, Zheng K, … Humphreys K
  • CONCLUSIONS: Internet search-based modeling should be explored as a new source of insights for predicting heroin-related admissions. In geographic regions where no current heroin-related data exist, Internet search modeling might be a particularly valuable and inexpensive tool for estimating changing heroin use trends. We discuss the immediate implications for using this approach to assist in managing opioid-related morbidity and mortality in the United States.
  • Extended-release morphine sulfate in treatment of severe acute and chronic pain. [Journal Article]
    J Pain Res. 2010 Sep 21; 3:191-200.Balch RJ, Trescot A
  • Morphine is the archetypal opioid analgesic. Because it is a short-acting opioid, its use has been limited to the management of acute pain. The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions. This review documents the history of morphine use in pain treatment, and describes the metabolism, pharmacodynamics, formulatio…
  • Anomalous observations of codeine in patients on morphine. [Journal Article]
    Ther Drug Monit. 2009 Dec; 31(6):776-8.West R, Crews B, … West C
  • Urine drug monitoring is used by physicians treating chronic pain patients with opioid therapy. Patients are tested in part to insure that they are not taking other drugs. Therefore, the finding of codeine in a patient who is only prescribed morphine has clinical implications. Morphine preparations are known to have small amounts of codeine as an impurity estimated to be about 0.04%. In a populat…
  • Avinza - 24-h sustained-release oral morphine therapy. [Review]
    Expert Opin Pharmacother. 2004 Feb; 5(2):469-72.Caldwell JR
  • Avinza is a once-daily, extended-release oral morphine preparation. It has a pharmacokinetic profile that exhibits less peak-to-trough fluctuations in plasma concentration whilst providing analgesia statistically identical to that produced by MS Contin (controlled-release morphine sulfate), Oxycontin (oxycodone HCl controlled-release) and six doses of oral morphine sulfate administered every 4 h.…
  • Avinza Elan. [Review]
    Curr Opin Investig Drugs. 2002 Sep; 3(9):1369-72.Semenchuk MR
  • Avinza is a once-daily morphine sulfate controlled-release formulation utilizing SODAS (Spheroidal Oral Drug Absorption System) technology developed by Elan and Ligand for the potential treatment of pain [220806], [223862]. This multiparticulate product is designed to provide a rapid onset of action together with a sustained therapeutic effect over 24 h. It is thought that once-daily administrati…
New Search